Ayyoun is a staff writer who loves all things gaming and tech. His journey into the realm of gaming began with a PlayStation 1 but he chose PC as his platform of choice. With over 6 years of ...

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

Potentially more than 90% of Alzheimer's disease cases would not occur without the contribution of a single gene (APOE), according to a new analysis led by UCL researchers. The scientists also found ...

This year’s flu season is shaping up to be a nasty one—driven by a new variant of the influenza virus that may be able to slip past our vaccine defenses. A mutated form of the influenza A strain H3N2 ...

Please provide your email address to receive an email when new articles are posted on . Prevalence of pathogenic variants in cancer-susceptibility genes appeared independent of personal or family ...

Boehringer Ingelheim has unveiled its second kidney-focused collaboration in recent weeks, this time penning a deal worth over $120 million biobucks with genomics-focused Variant Bio. The alliance ...

A new flu variant fueling a fast-paced rise in cases across the state has brought with it some symptoms unlike those many have come to associate with the virus. As cases reach "very high" levels in ...

Influenza A (H3N2) viruses appear to have entered a new phase of evolution. Analysis of more than 24,000 viral sequences revealed increasing diversification within clade J.2 and the emergence of a new ...

Salonen, the LA Phil's Conductor Laureate—who will begin a five-year term as Creative Director beginning in the 2026/27 season—joins the Los Angeles Philharmonic, Los Angeles Master Chorale, pianist ...

Here’s what to know about the dominant version of the virus that’s circulating now. By Dani Blum The flu constantly morphs and mutates. Often, it surprises researchers a little. This year, the virus ...

Flu season is among us, and a new strain has emerged as a major threat. A mutation of influenza A H3N2, called subclade K, has been detected as the culprit in rising global cases, including in the U.S ...